CREPT and p15RS are two recently identified homologous proteins that regulate cell proliferation in an opposite way and are closely related to human cancer development. Both CREPT and p15RS consist of an N-terminal RPR domain and a C-terminal domain with high sequence homology. The transcription enhancement by CREPT is attributed to its interaction with RNA polymerase II (Pol II). Here we provide biochemical and structural evidence to support and extend this molecular mechanism. Through fluorescence polarization analysis, we show that the RPR domains of CREPT and p15RS (CREPT-RPR and p15RS-RPR) bind to different Pol II C-terminal domain (CTD) phosphoisoforms with similar affinity and specificity. We also determined the crystal structure of p15RS-RPR. Sequence and structural comparisons with RPR domain of Rtt103, a homolog of CREPT and p15RS in yeast, reveal structural basis for the similar binding profile of CREPT-RPR and p15RS-RPR with Pol II CTD. We also determined the crystal structure of the C-terminal domain of CREPT (CREPT-CTD), which is a long rod-like dimer and each monomer adopts a coiled-coil structure. We propose that dimerization through the C-terminal domain enhances the binding strength between CREPT or p15RS with Pol II by increasing binding avidity. Our results collectively reveal the respective roles of N-terminal RPR domain and C-terminal domain of CREPT and p15RS in recognizing RNA Pol II.
Tumor development is highly related to uncontrolled cell growth [1] , a process in which oncogenes and tumor suppressor genes are both involved [2] . CREPT (cell-cycle related and expression-elevated protein in tumor, another name RPRD1B) and p15RS (p15INK4b-related sequence, another name RPRD1A), two recently identified genes, are a pair of highly related genes that have opposite functions in regulating cell proliferation [3, 4] . The encoded protein of p15RS is related to p15INK4b, a cyclin-dependent kinase inhibitor, and its expression inhibits cell proliferation [3, 5, 6] . By contrast, CREPT protein promotes cell proliferation by enhancing transcription of cell cycle related genes including the CYCLIN D1 and is highly expressed in diverse human tumors [4] . The proposed molecular mechanism of transcription enhancement by CREPT is the formation of a chromatin loop that recycles RNA polymerase II (Pol II) from the termination site to the promoter region of a target gene [4] . Interestingly, Rtt103, an ancestor of both CREPT and p15RS in yeast, was demonstrated to play an important role in the regulation of yeast growth [7] . Recently, Rtt103 was also demonstrated to function in DNA damage response [8] .
RNA Pol II has a unique C-terminal domain (CTD) in its largest subunit RPB1, which is composed of multiple tandem repeated heptapeptides with the consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 with up to 52 repeats in mammals [911] . Dynamic and reversible modification of the Pol II CTD is essential for the efficient and accurate completion of transcription cycle [12, 13] . The different modification state of CTD, particularly in the positions of Ser2 and Ser5, is closely related to the coordination and recruitment of transcription and mRNA processing factors to RNA Pol II [1316] . In the early stage of transcription, Ser5 phosphorylation (Ser5P) recruits the mRNA capping enzymes [1719] . As RNA Pol II progresses into the elongation phase, the level of Ser2 phosphorylation (Ser2P) increases while the level of Ser5P decreases [16] . At the late stage of transcription, Ser2P is the most dominating modification form of CTD in RNA Pol II, leading to increased recruitment of factors responsible for cleavage and polyadenylation [14] .
Both CREPT and p15RS consist of an N-terminal RPR domain and a C-terminal domain with high sequence similarity, with only significant sequence variations in the linker region connecting these two domains [4] . The RPR domain is reported in several RNA processing and transcription termination factors and functions as a classical RNA Pol II CTD binding domain [2023] . Rtt103, a homolog of CREPT and p15RS in yeast, functions as a transcription terminator and also contains a RPR domain [23] . It associates with Pol II in the termination region at the 3′-end of a gene with the RPR domain to trigger the transcription termination of a gene together with Rai1, which favors the torpedo model of transcription termination [7] . Biochemical and structural studies have shown that the RPR domain of Rtt103 directly binds to the Ser2P CTD of RNA Pol II [23] . Our recent study showed that CREPT physically interacts with RNA Pol II [4] . Chromatin immunoprecipitation (ChIP) experiment further indicated that CREPT associates with the 5′ promoter region of the CYCLIN D1 gene [4] , which is different from Rtt103. Therefore, we proposed that CREPT might promote the recycling of RNA Pol II from the terminator to the promoter region, which was supported by the chromosome conformation capture (3C) experiment showing that CREPT promotes the formation of a chromatin loop [4] .
Although our previous study has shed light on the transcription enhancement by CREPT, the molecular mechanism underlying the opposite effects of CREPT and p15RS in cell proliferation remains elusive. Structural and biochemical studies of the RPR domain and C-terminal domain in CREPT and p15RS have not been reported yet. In this study, we report the crystal structures of the N-terminal RPR domain of p15RS (p15RS-RPR) and the C-terminal domain of CREPT (CREPT-CTD).
Materials and methods

Protein expression and purification
The coding sequences of human CREPT-RPR domain (residues 1132) and p15RS-RPR domain (residues 1131) were cloned into pET22b vector with a C-terminal His tag. Escherichia coli BL21 (DE3) cells harboring expression constructs were grown at 37°C in LB medium containing 100 mg L 1 ampicillin. Expression of target proteins was induced by addition of isopropyl-β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 0. 
Co-immunoprecipitation
CREPT and different truncation plasmids were generated by inserting the PCR-amplified fragments into a pcDNA3.1-Myc vector. CREPT was also inserted into a pcDNA3.1-flag vector to obtain the plasmid used for common immunoprecipitation bait. HEK293T cells were plated in 60 mm dishes the day before transfection. Plasmids (2 µg) were transfected. Cells were lysed 2436 h after transfection in 900 µL of cell lysis buffer (50 mmol L 1 Tris-Cl, 150 mmol L 1 NaCl, 50 mmol L 1 NaF, 0.5% NP-40, pH 7.5) with protease inhibitors to prepare whole cell lysates. Lysates were mixed with anti-Myc and protein G-agarose beads and incubated at 4°C overnight. Immunoprecipitants and 5% of lysates were analyzed by immunoblotting for the indicated proteins.
Multiple-angle light scattering (MALS)
The molecular masses of CREPT-CTD and CREPT-CTD_177-280 in solution were determined by MALS using the DAWN HELEOSTM II 18-angle static light-scattering system (Wyatt Technology, USA), connected to an Agilent HPLC, and hooked up with a WTC SEC column (Wyatt Technology, USA). The system was first equilibrated with buffer containing 50 mmol L 1 Tris-Cl (pH 8.0) and 150 mmol L 1 NaCl for more than 12 h. The equilibrated system was then calibrated with BSA at a concentration of 1 mg mL 1 . CREPT-CTD and CREPT-CTD_177-280 were prepared in the aforementioned process and concentrated to 1 mg mL 1 . Samples were injected to MALS analyzer at a flow rate of 0.5 mL min 1 at 16°C. The molecular mass was calculated using ASTRA5.3.4.14 software (Wyatt Technology, uSA).
Crystallization and data collection
Proteins were prepared as described above. 
Structural determination and refinement
The structure of p15RS-RPR domain was determined by the molecular replacement method with program PHASER [26] , and the search model is Rtt103-RPR NMR structures (PDB code 2KM4). After we collected the native diffraction data of CREPT-CTD, the structure of RPRD1B C-terminal domain was released (PDB code 4FLA), which is the same protein as CREPT-CTD. We therefore utilized it directly to determine the structure of CREPT-CTD using the molecular replacement method with program PHASER [26] . Structure refinement and model building were conducted with programs PHENIX and COOT, respectively [27, 28] . The quality of the model was checked with program PROCHECK [29] .
Results
CREPT and p15RS recognize RNA Pol II CTD phosphoisoforms similarly
We initially hypothesized that the opposite effects of CREPT and p15RS in the regulation of cell proliferation might result from their different binding specificity and affinity with RNA Pol II CTD. This hypothesis was supported by previous studies showing that the RPR domains from different transcription factors have different preferred CTD phosphoepitopes [2023] . It has been documented that major phosphorylation sites on RNA Pol II CTD are on Ser2, Ser5 and Ser7 [15, 23] , and the smallest functional unit of RNA Pol II CTD in in vitro biochemical studies has been defined as two consecutive heptad peptides [21, 24] . Therefore, we compared the binding affinities of CREPT-RPR and p15RS-RPR for a panel of synthetic diheptad CTD peptides with different phosphoepitopes ( Figure 1A ) by fluorescence polarization. In this experiment, the CREPT-RPR (residues 1-132) and p15RS-RPR (residues 1131) with a C-terminal six histidine tag were both expressed in BL21(DE3) bacteria and purified with Nickel resin followed by size-exclusion chromatography. Both RPR domains are monomeric in solution ( Figure S1 in Supporting Information).
Our fluorescence polarization analysis showed that CREPT-RPR and p15RS-RPR bound to the Ser2P RNA Pol II CTD with similar affinities of 12.3 and 13.7 µmol L 1 , respectively ( Figure 1B ). Both RRP domains bound to unphosphorylated and Ser7P RNA Pol II CTD much weaker with ~36 fold decreased affinities ( Figure 1B ). CREPT-RPR and p15RS-RPR showed the weakest binding with Ser5P RNA Pol II CTD. The p15RS-RPR bound to Ser5P RNA Pol II CTD with an affinity of less than 1 mmol L 1 , and CREPT-RPR did not bind to Ser5P RNA Pol II CTD in fluorescence polarization experiment ( Figure 1B) . These results suggest that CREPT-RPR and p15RS-RPR exhibit similar binding specificity and affinity with RNA Pol II CTD, and Ser2P RNA Pol II CTD is the most preferred binding phosphoisoform.
The structure of p15RS-RPR
The crystal structure of p15RS-RPR was determined by the molecular replacement method and refined to a resolution of 2.0 Å with R work of 17.4% and R free of 21.4% (Table 1) . There are two molecules in an asymmetric unit in a sub-vertical orientation ( Figure S2 in Supporting Information). For each molecule, the structure identifies a compact eight-helix bundle in a right-handed super-helical arrangement ( Figure 2A ). The structure of p15RS-RPR is very similar to that of the yeast Rtt103-RPR domain with 1.3 Å Cα r.m.s. deviation over the entire length of the polypeptide ( Figure 2B ). Amino acids in the hydrophobic core of p15RS-RPR and Rtt103-RPR are highly conserved in CREPT-RPR ( Figure 2C ), suggesting that CREPT-RPR domain also adopts a similar eight-helix structure with super-helical arrangement. A previously reported complex structure of Rtt103-RPR with a diheptad Pol II CTD peptide with two Ser2 phosphorylation positions showed that the peptide binds along helices 2, 4, and 7 of Rtt103-RPR [23] , which are also the most structurally conserved helices between Rtt103-RPR and p15RS-RPR ( Figure 2B ). Rtt103 residues binding to the peptide are highly conserved in p15RS-RPR and CREPT-RPR ( Figure 2B and C) . The direct salt-bridge interaction between Arg108 in helix 7 of Rtt103 and the phosphate group of Ser2 position ( Figure 2B ) was suggested to be critical in determining the preference for Ser2P Pol II CTD over other phosphoisoforms [23] . This arginine residue is conserved in this position in p15RS-RPR and CREPT-RPR ( Figure 2C ). We expect that this arginine residue in p15RS-RPR and CREPT-RPR will also bind to the phosphate group of Ser2, which is critical in determining their binding preference among different phosphopeptides. Indeed, our fluorescence polarization analysis showed that p15RS-RPR and CREPT-RPR bind preferentially to Ser2P Pol II CTD (Figure 1 ).
The structure of CREPT C-terminal domain
Compared with the N-terminal RPR domain, no structure information is available for the C-terminal domain of CREPT and p15RS. We purified the CREPT-CTD (residues 177-326) expressed in BL21 (DE3) bacteria and determined its structure at 2.8 Å resolution with R work of 24.0% and R free of 29.0% (Table 1) . CREPT-CTD is an elongated, rodshaped dimer, with dimensions of ∼30×30×140 Å ( Figure  3A ). Each monomer in the structure consists of residues Thr177 to Leu305, and other residues at the C-terminal tail were not built due to weak electron densities. The Nterminal region of CREPT-CTD monomer consists of three short helices α1 (Thr177-Ala190), α2 (Gly193-Ala202), and α3 (Val211-Lys216) that run approximately half the length of the rod ( Figure 3A and B) . After a short loop of three residues, a very long helix α4 (Lys220-Ile297) runs the entire length of the rod ( Figure 3A and B) . The helix α4 is continuous and has the shape of a long arch ( Figure 3A) . Two CREPT-CTD monomers interlock to form a symmetric dimer. The N termini of the two monomers (helix α1) are close together at the middle of the rod, and the C termini are at the opposite ends of the rod, far away from each other ( Figure 3A ).
Inter-chain interactions in CREPT-CTD
We further analyzed the inter-chain interactions of CREPT-CTD. Upon interlocked into a dimer, the long and symmetric binding interface between two CREPT-CRD monomers (A and B) have a very large buried surface of ~6400 Å 2 (3200 Å 2 each monomer). The two antiparallel longest α4 helices running the entire length of the dimer form a coiled-coil structure, which forms the frame of the dimer ( Figure 4A ). Due to the symmetric nature of the binding interface, here we only describe the interacting residues in the half of the interface. Hydrophobic residues involved in the interactions between the α4 helices include Figure 4A ). At the two far ends of the dimer, the C-terminal tail of the α4 helix further interacts with the short α3 helix of another monomer, forming (Figure 4B ). At the middle of the dimer, the N-terminal α1 helices of monomers A and B have an antiparallel interaction, and the interacting hydrophobic residues include Leu180, Ile181, and Leu184 from each monomer ( Figure 4C ).
We proposed that the full-length CREPT might form a dimer mediated by the association of its CTD domain because the N-terminal RPR domain is monomeric in solution ( Figure S1A in Supporting Information). To test this hypothesis, we measured the interaction of Flag-CREPT with Myc-CREPT expressed in 293T cells with immunoprecipitation method. In particular, we checked the effects of C-terminal truncations of Myc-CREPT on the association with full-length Flag-CREPT as the crystal structure shows that the C-terminal end of the α4 helix is involved in the CREPT-CTD dimer formation ( Figure 4B ). The IP results indicated that the C-terminal truncated Myc-CREPT mutants CREPT_1-285, CREPT_1-290, CREPT_1-295 and CREPT_1-300 deleting residues from 286, 291, 296 and 301 amino acid positions retained the interaction with Flag-CREPT, as strong as the interaction of full length Myc-CREPT with Flag-CREPT ( Figure 5A ). Deleting the C-terminal region from Val286 did not interfere with the interaction between CREPT monomers, but deleting five more residues from Gln281 to Arg285 abolished the inter- action ( Figure 5A ). Considering the interaction between full length CREPT is mediated by the C-terminal domain, we further generated a CREPT-CTD C-terminal truncation deleting residues from Gln281 (CREPT-CTD_177-280). Multiple-angle light scattering (MALS) analysis showed that most of CREPT-CTD_177-280 is monomer in solution, while the wild type CREPT-CTD is dimer ( Figure 5B ). This further supported that the C-terminal end of α4 helix is important for the dimer formation of CREPT-CTD, which mediates the interaction between full-length CREPT.
Discussion
CREPT is a recently identified oncogene that is highly expressed in different tumors [4] . It has been observed that CREPT promotes cell proliferation by enhancing the expression of cell-cycle-related genes [4] . On the other hand, the expression of p15RS, a homologous protein of CREPT, was reported to inhibit cell proliferation [3] , functioning as an intrinsic inhibitor of Wnt signaling mediated transcription [5] . CREPT and p15RS both contain an N-terminal RPR domain, which recognizes RNA Pol II CTD, and a C-terminal domain with unknown function. Interestingly, both domains of CREPT and p15RS share high sequence identities. In this study, we performed biochemical and structural studies on the RPR and C-terminal domains, trying to figure out their respective roles in recognizing RNA Pol II CTD by CRETP of p15RS and explain the opposite function of CREPT and p15RS in regulating cell proliferation.
Our results demonstrated that the N-terminal RPR domain of CREPT and p15RS are very similar in binding Ser2P Pol II CTD, with higher affinity than other Pol II CTD phosphoisoforms (Figure 1 ). Structural determination of p15RS RPR domain and comparison with yeast Rtt103 RPR domain showed that critical residues for the interaction with Ser2P diheptapeptide are conserved in them, as well as in CREPT ( Figure 2B and C) , revealing a structural basis for the binding preference to Ser2P diheptapeptide by CREPT and p15RS. We previously have shown that CREPT is able to bind RNA Pol II at the promoter and terminator regions of genes and proposed that it recycles the Pol II to the 5′ promoter region by a chromatin loop [4] . RNA Pol II at the late stage of transcription is modified by phosphorylation at Ser2 positions of RNA Pol II CTD, while Ser5P is the most dominating modification state of CTD before the late stage of transcription [10, 13, 15, 17] . Our fluorescence polarization analysis showed that CREPT-RPR did not bind to the Ser5P diheptapeptide, even weaker than the binding with the unphosphorylated diheptapetpide ( Figure 1) . Therefore, we proposed that CREPT might selectively associate with Ser2P CTD of RNA Pol II at the 3′ terminal end of a transcribing gene. Whether the preferred interaction of CREPT with Ser2P CTD of RNA Pol II would facilitate the formation of a chromatin loop by the association with 5′ promoter region remained to be examined. Currently, we are not clear about the molecular basis of the association of CREPT with 5′ promoter region of a gene. Since CREPT failed to associate with Ser5P CTD of RNA Pol II, which remains at a high level in the promoter region during the transcription initiation, we speculate that other proteins that could bind to DNA might associate with Ser5P CTD of RNA Pol II and CREPT simultaneously to regulate the status of RNA Pol II in the promoter region.
The RPR domain has also been found in several RNA processing and transcription termination factors other than CREPT and p15RS [20, 22, 23] . The RPR containing proteins additionally have other domains responsible for protein-protein and protein-RNA interactions such as Pcf11, Rtt103, and SCAF8. However, CREPT and p15RS contain only the RPR domain, except their conserved C-terminal domain without a high sequence homology with other proteins. The structure of CREPT-CTD shows that C-terminal domain of CREPT forms a very long rod-like dimer, each monomer adopting a coiled-coil structure ( Figure 3A) . We analyzed the interactions between two CREPT-CTD domains and found that the C-terminal residues from Gln281 to Arg285 are critical for the dimer formation of the CREPT-CTD in solution ( Figure 5B), as well as for the interaction between full length CREPT monomers ( Figure 5A ) when they associate together to form a dimer or other aggregated forms in the cell.
We searched the Dali server and identified some proteins containing a similar coiled-coil structure as the CREPT-CTD but with diverse functions (data not shown). The coiled-coil structure is a popular structural motif found in many proteins, structural similarity therefore is not able to provide further insights into the function of CTD in CREPT and p15RS. We propose that CREPT may form a dimer in the association with RNA Pol II. It is speculated that the CREPT-CTD dimer might directly enhance the interaction of CREPT with RNA Pol II. The N-terminal RPR domain functions as a monomer, supported by both biochemical data and the crystal structure ( Figure S1A in Supporting Information; Figure 2A ). The complex structure of Rtt103-RPR domain with Ser2P diheptapeptide suggests that the RPR domain monomer has one binding site for the peptide, especially for the Ser2P [23] . The RNA Pol II CTD consists of up to 52 heptapeptide repeats [11] . The full-length CREPT holds a very stable dimer in its C-terminal domain, and two N-terminal RPR domains are linked to the C-terminal dimer via a long linker ( Figure 6 ). The flexibility of the linker enables the two RPR domains to interact with the RNA Pol II CTD with Ser2P individually with a similar affinity. The dimeric CREPT complex that has two Pol II CTD binding sites is expected to increase the binding avidity with Pol II CTD.
The functional role of the RPR domain in direct association with RNA Pol II CTD has been studied [2023]. Here we firstly report the dimer structure of CREPT C-terminal domain and propose that one function of CREPT-CTD dimer is to increase binding strength of CREPT with Pol II CTD ( Figure 6 ). We expect that the RPR and C-terminal domains in p15RS would have similar functions because the highly conserved primary amino acid sequences in these two domains ( Figure S3 in Supporting Information) and our MALS data showed that p15RS-CTD is dimer in solution ( Figure S4 in Supporting Information). This raises an interesting question still not answered: what is the molecular mechanism underlying the opposite function in regulating cell proliferation by CREPT and p15RS? Besides the proposed role of increasing binding avidity, we cannot exclude that the similar C-terminal domains of CREPT and p15RS bind to different protein partners that would determine their 
PDB Deposition
The coordinates and diffraction data have been deposited into the Protein Data Bank with accession codes of 4NAC for p15RS-RPR and 4NAD for CREPT-CTD.
Supporting Information
Figure S1 Gel-filtration of CREPT-RPR (A) and p15RS-RPR (B). The coordinate graph on the top right of each figure is a plot of log molecular weight against elution volume of the column. Gel filtration standards (Bio-Rad) used in the experiment were vitamin B12 (1.3 kD), horse myoglobin (17 kD), chicken ovalbumin (44 kD), bovine gamma-globulin (158 kD), and bovine thyroglobulin (670 kD). Theoretical molecular weight of CREPT-RPR and p15RS-RPR monomer is 15.283 and 15.22 kD, respectively. Calculated molecular weight from gel filtration of CREPT-RPR and p15RS-RPR is 14.092 and 14.628 kD, indicating that CREPT-RPR and p15RS-RPR are monomers. The supporting information is available online at life.scichina.com and link.springer.com. The supporting materials are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains entirely with the authors.
